Healthcare provider profile · identity verified

Chanchal D Sabharwal, MD

Internal Medicine · SOUTH RICHMOND HILL, NY · NPI 1134303969

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1207	367
Amlodipine Besylate	Amlodipine Besylate	852	271
Metformin Hcl	Metformin Hcl	502	155
Losartan Potassium	Losartan Potassium	500	159
Levothyroxine Sodium	Levothyroxine Sodium	382	102
Metoprolol Succinate	Metoprolol Succinate	355	119
Irbesartan	Irbesartan	278	85
Albuterol Sulfate Hfa	Albuterol Sulfate	270	72
Simvastatin	Simvastatin	265	84
Jardiance	Empagliflozin	253	65
Omeprazole	Omeprazole	248	85
Glimepiride	Glimepiride	243	72
Gabapentin	Gabapentin	234	79
Lisinopril	Lisinopril	227	75
Janumet	Sitagliptin Phos/Metformin Hcl	211	46
Famotidine	Famotidine	190	52
Tamsulosin Hcl	Tamsulosin Hcl	184	60
Rosuvastatin Calcium	Rosuvastatin Calcium	181	62
Hydralazine Hcl	Hydralazine Hcl	178	58
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	162	48
Diclofenac Sodium	Diclofenac Sodium	160	62
Metoprolol Tartrate	Metoprolol Tartrate	153	53
Alendronate Sodium	Alendronate Sodium	150	53
Januvia	Sitagliptin Phosphate	150	40
Metformin Hcl Er	Metformin Hcl	144	46
Eliquis	Apixaban	142	38
Hydrochlorothiazide	Hydrochlorothiazide	137	43
Carvedilol	Carvedilol	136	42
Ozempic	Semaglutide	132	21
Atenolol	Atenolol	128	39
Clopidogrel	Clopidogrel Bisulfate	114	40
Meloxicam	Meloxicam	109	31
Finasteride	Finasteride	106	30
Furosemide	Furosemide	99	39
Synthroid	Levothyroxine Sodium	86	24
Novolog Flexpen	Insulin Aspart	85	28
Glipizide	Glipizide	84	24
Meclizine Hcl	Meclizine Hcl	79	38
Allopurinol	Allopurinol	77	26
Montelukast Sodium	Montelukast Sodium	77	24
Ibuprofen	Ibuprofen	76	44
Ezetimibe	Ezetimibe	73	30
Naproxen	Naproxen	72	31
Fluticasone Propionate	Fluticasone Propionate	71	33
Pantoprazole Sodium	Pantoprazole Sodium	71	25
Single Use Swab	Alcohol Antiseptic Pads	69	23
Warfarin Sodium	Warfarin Sodium	67	suppressed
Azithromycin	Azithromycin	64	56
Pravastatin Sodium	Pravastatin Sodium	60	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	21
Alcohol Prep Pads	Alcohol Antiseptic Pads	52	20
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	52	11
Mounjaro	Tirzepatide	52	suppressed
Donepezil Hcl	Donepezil Hcl	51	23
Escitalopram Oxalate	Escitalopram Oxalate	51	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	16
Ammonium Lactate	Ammonium Lactate	48	11
Glipizide Er	Glipizide	48	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	16
Triamcinolone Acetonide	Triamcinolone Acetonide	47	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	40
Lovastatin	Lovastatin	45	15
Nifedipine Er	Nifedipine	43	13
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	43	13
Alprazolam	Alprazolam	42	13
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	42	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	42	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	41	13
Pioglitazone Hcl	Pioglitazone Hcl	41	12
Prednisone	Prednisone	41	31
Pregabalin	Pregabalin	39	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	38	11
Enalapril Maleate	Enalapril Maleate	38	12
Sertraline Hcl	Sertraline Hcl	37	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	19
Ketoconazole	Ketoconazole	36	24
Lactulose	Lactulose	34	13
Betamethasone Dipropionate	Betamethasone Dipropionate	33	20
Tresiba Flextouch U-200	Insulin Degludec	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	24
Hydrocortisone	Hydrocortisone	32	suppressed
Tresiba Flextouch U-100	Insulin Degludec	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Potassium Chloride	Potassium Chloride	30	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Spironolactone	Spironolactone	28	suppressed
Valsartan	Valsartan	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Nystatin	Nystatin	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Fluconazole	Fluconazole	20	13
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Ramipril	Ramipril	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Baclofen	Baclofen	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	17	15
Acetic Acid	Acetic Acid	16	15
Alcohol Swabs	Alcohol Antiseptic Pads	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Methimazole	Methimazole	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Novofine 32	Pen Needle, Diabetic	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error